Document Type : Original Article
Authors
1 Department of Pediatric Dentistry, Torabinejad Dental Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Operative Dentistry, Dental Materials Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
3 Department of Pediatric Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran.
Abstract
Objective: Addition of vasoconstrictors to local anesthesia results in prolonged pain
control. However, associated soft‑tissue anesthesia (STA) of the lips and tongue typically lasts
3‑5 hours which is longer than required time for pain control after routine dental procedures
can lead to inadvertent biting of the soft tissue, particularly in children. The present study
aimed to evaluate phentolamine mesylate (PM) effect on duration of STA and incidence of
soft‑tissue trauma after mandibular block injection.
Methods: This randomized, double‑blinded, controlled clinical trial included 54 patients
with the age of 4‑11 years. In group 1 at the first visit, the children received ordinary local
anesthetic (LA) consisting of lidocaine 2% and epinephrine 1:80,000 and the PM injection was
performed 30 minutes later. At the second visit, the contralateral side received LA injection
then the dental procedure was done and a sham injection was performed. In group 2 at the
first visit, patients received control injection and at the second visit received PM injection.
Then the reversal time for normal sensation of soft tissue, the vital signs, and the incidence
of soft‑tissue trauma in a period of 3‑5 hours after injection were evaluated.
Findings: There was a statistically significant difference (P < 0.001) in recovery time of normal
lip sensation between case and control groups and also between two groups (P < 0.003).
Incidence of soft‑tissue trauma between case and control groups showed a statistically
significant difference (P < 0.039).
Conclusion: PM can be considered as a safe and effective drug for reduction of reversal
time of STA after dental procedures.
Keywords
Assessing the duration of mandibular soft tissue anesthesia.
J Am Dent Assoc 1995;126:1531‑6.
2. Malamed SF, Local anesthesia reversal. American Dentistry
Association [Continuing Education], 2009; Available from:
http://www.oraverse.com/assets/pdf/dtce_malamed_mar10.
pdf. [Last accessed 2012 March 8].
3. Malamed SF. Pharmacology of vasoconstrictors. In:
Malamed SF, editor. 5th ed. Handbook of local anesthesia. St.
Louis: Mosby; 2004. p. 41‑54.
4. College C, Feigal R, Wandera A, Strange M. Bilateral versus
unilateral mandibular block anesthesia in a pediatric
population. Pediatr Dent 2000;22:453‑7.
5. Rafique S, Fiske J, Banerjee A. Clinical trial of an airabrasion/
chemomechanical operative procedure for the restorative
treatment of dental patients. Caries Res 2003;37:360‑4.
6. Rutherford B, Zeller JR, Thake D. Local and systemic
toxicity of intraoral submucosal injections of phentolamine
mesylate (OraVerse), Anesth Prog 2009;56:123‑7.
7. Malamed SF, Phentolamine mesylate for the reversal of
residual soft-tissue anesthesia. ADA [Continuing Education],
2009; Available from: http://www.ineedce.com/courses/2088/
PDF/1103cei_phentolamine_web.pdf. [Last accessed 2012
March 8].
8. Yagiela JA, Dowd FJ, Neidle EA. Pharmacology and
Therapeutics for Dentistry. St. Louis: Mosby; 2004.
p. 251‑70.
9. McGovern SJ. Treatment of accidental digital injection of
adrenaline from an auto‑injector device. J Accid Emerg Med
1997;14:379‑80.
10. Koss MC. Differential neural activation of vascular
alpha‑adrenoceptors in oral tissues of cats. Eur J Pharmacol
2002;440:53‑9.
11. Approval letter for phentolamine mesylate. U.S. Food and
Drug Administration, US: Center for Drug Evaluation and
Research. 1998.
12. Package insert. Regitine (Phentolamine mesylate injection,
USP). Woodbridge, NJ: Ciba Pharmaceuticals; 1999.
13. US Food and Drug Administration Center for Drug
Evaluation and Research, Approval letter for phentolamine
mesylate. 1998. Available from: http://www.fda.gov/cder/foi/
anda/98/40235ap.pdf. [Last accessed on 2007 May 5].
14. Hersh EV, Moore PA, Papas AS, Goodson JM, Navalta LA,
Rogy S, et al. The Soft Tissue Anesthesia Recovery Group.
Reversal of soft‑tissue local anesthesia with phentolamine
mesylate in adolescents and adults. J Am Dent Assoc
2008;139:1080‑93.
15. Tavares M, Goodson JM, Studen‑Pavlovich D, Yagiela JA,
Navalta LA, Rogy S, et al. Reversal of soft tissue local
anesthesia with phentolamine mesylate in pediatric patients.
J Am Dent Assoc 2008;139:1095‑104.
16. Fonseca. Oral and maxillofacial surgery. 2nd ed. United states:
Saunders Elseviers; 2009. p. 289‑92.
17. Moore PA, Hersh EV, Papas AS, Goodson JM, Yagiela JA,
Rutherford B. Pharmacokinetics of lidocaine with epinephrine
following local anesthesia reversal with phentolamine
mesylate. Anesth Prog 2008;55:40‑8.
18. Saunders TR, Psaltis G, Weston JF, Yanase RR, Rogy SS,
Ghalie RG. In‑practice evaluation of OraVerse for the reversal
of soft‑tissue anesthesia after dental procedures. Compend
Contin Educ Dent 2011;32:58‑62.
19. Hersh EV, Lindemeyer RG. Phentolamine mesylate for
accelerating recovery from lip and tongue anesthesia. Dent
Clin North Am 2010;54:631‑42.
20. Laviola M, McGavin SK, Freer GA, Plancich G, Woodburg SC,
Marincovich S, et al. Randomized study of phentolamine
mesylate for reversal of local anesthesia. J Dent Res
2008;87:635‑9
)